trending Market Intelligence /marketintelligence/en/news-insights/trending/ea1BcEK0Lo5DgfX3GxhYwA2 content esgSubNav
In This List

Bellerophon Therapeutics principal financial officer to resign

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Bellerophon Therapeutics principal financial officer to resign

Megan Schoeps intends to resign as Bellerophon Therapeutics Inc.'s controller and principal financial officer to pursue other career interests.

Schoeps is expected to continue in her current role until about January 2018 while the company completes an ongoing search for a replacement. She is also expected to provide transition assistance, as needed.